ARKG

ARK Genomic Revolution ETF
*Unless otherwise stated, data provided by FactSet.

ARKG Fund Description

ARKG is an actively managed fund that targets companies involved in the genomics industry.

ARKG Factset Analytics Insight

ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. Such companies are those that may develop, produce or enable targeted therapeutics, bioinformatics, stem cells or molecular diagnostics. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund which employs an actively-managed strategy, hence investors should look closely at where the fund makes its bets before investing.

ARKG MSCI ESG Analytics Insight

ARK Genomic Revolution ETF has an MSCI ESG Fund Rating of BB based on a score of 3.97 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. ARK Genomic Revolution ETF ranks in the 13th percentile within its peer group and in the 23th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

ARKG MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 06/10/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
ARKG 5.12% -3.39% -8.85% 89.20% 44.75% 38.82% --
ARKG (NAV) 14.32% -1.06% -6.48% 92.01% 46.05% 40.22% --
No Underlying Index -- -- -- -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

ARKG Summary Data

ARK
10/31/14
Open-Ended Fund
0.75%
$8.74B
$240.58M
0.04%

ARKG Portfolio Data

$37.70B
-57.31
4.74
0.91%
N/A
56

ARKG Index Data

No Underlying Index
Proprietary
Proprietary
N/A

ARKG Portfolio Management

0.75%
--
--
--

ARKG Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

ARKG Fund Structure

Open-Ended Fund
No
No
-- / --
N/A
N/A
Low
Daily

ARKG Factset Analytics Block Liquidity

As of 06/11/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of ARKG. ARKG is rated a 5 out of 5.

ARKG Tradability

2,927,509
$240.58M
2,409,499
$208.24M
0.04%
$0.03
0.08%
0.33% / -0.22%
None
95.00%
50,000
48.19
0.06%
0.23%
378,588
$87.23
5

ARKG Sector/Industry Breakdown


ARKG
Segment Benchmark
92.52%
10.99%
3.80%
25.45%
0.17%
6.60%

ARKG Countries


ARKG
Segment Benchmark
88.02%
57.99%
7.39%
2.32%
3.44%
6.51%
0.97%
2.71%
0.17%
0.17%
--
0.01%
--
0.00%
--
0.05%
--
0.01%
--
0.01%

ARKG Regions


ARKG
Segment Benchmark
88.02%
60.92%
8.37%
17.12%
3.44%
19.66%
0.17%
1.30%
--
1.01%

ARKG Economic Development


ARKG
Segment Benchmark
100.00%
94.69%
--
5.31%

ARKG Performance Statistics

--
--
--
--
0.00%
N/A

ARKG MSCI ESG Ratings

3.97 / 10
22.88
12.65
0.21%
13.36%
20.51

ARKG Benchmark Comparison Holdings

56
8996
43
1.80%

ARKG Benchmark Comparison Summary


ARKG
Segment Benchmark
56
8996
$37.70B
$284.92B
-57.31
37.11
4.74
2.80
0.50%
1.64%
Medium
Low

ARKG Benchmark Comparison Market Cap Size


ARKG
Segment Benchmark
44.26%
80.22%
41.86%
14.95%
12.09%
4.47%
1.78%
0.36%